← Back to headlines
Novartis bets on pipeline as Big Pharma seeks growth through acquisitions
An analysis suggests that while Big Pharma companies are acquiring growth, Novartis is strategically betting on its internal drug development pipeline for future expansion.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
